Tysabri Alternatives Compared
Tysabri | Entyvio | Pentasa |
|
---|
Tysabri (natalizumab) | Entyvio (vedolizumab) | Pentasa (mesalamine) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Tysabri may be used to treat adults with multiple sclerosis or Crohn's disease and is given once every four weeks through an infusion center registered with the Touch Prescribing Program. A headache... View more |
Prescription only
Entyvio infusion is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically... View more |
Prescription only
Prescribed for Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance, Ulcerative Proctitis. Pentasa may also be... View more |
Related suggestions Crohn's Disease, Maintenance
|
|||||||||||||||||||||||
More about Tysabri (natalizumab) | More about Entyvio (vedolizumab) | More about Pentasa (mesalamine) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Tysabri has an average rating of 7.8 out of 10 from a total of 98 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 15% reported a negative effect. |
Entyvio has an average rating of 6.1 out of 10 from a total of 152 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 29% reported a negative effect. |
Pentasa has an average rating of 7.8 out of 10 from a total of 88 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Tysabri side effects in more detail. |
See also: Entyvio side effects in more detail. |
See also: Pentasa side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Tysabri prices |
View all Entyvio prices |
View all Pentasa prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other natalizumab brands include: Tyruko | Other vedolizumab brands include: Entyvio Pen | Other mesalamine brands include: Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
360 hours |
600 hours |
10 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 405 drugs are known to interact with Tysabri:
|
A total of 152 drugs are known to interact with Entyvio:
|
A total of 120 drugs are known to interact with Pentasa:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
November 23, 2004 |
May 20, 2014 |
May 10, 1993 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.